Therefore, because AAs have relatively higher levels of HDL-C, it is possible that HDL-C interacts with APOE to reduce the ɛ4 allele-related AD risk and, importantly, lower the rates of disease progression in this population. This evidence concerns the gene APOE and Alzheimer disease.